Lacosamide: new adjunctive treatment for partial seizures

Lacosamide (Vimpat), which is hypothesised to have a novel dual mode of action, is a new antiepileptic drug licensed as adjunctive therapy for partial seizures. In our New products review Steve Chaplin presents the clinical data relating to its efficacy and adverse effects, and Dr Yvonne Hart comments on its place in treatment. Copyright © 2009 Wiley Interface Ltd